Nóra Gyémánt
About
In The Last Decade
Nóra Gyémánt
24 papers receiving 705 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 410
- Oncology 202
- Organic Chemistry 117
- Pharmacology 99
- Biochemistry 93
Countries citing papers authored by Nóra Gyémánt
This map shows the geographic impact of Nóra Gyémánt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nóra Gyémánt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nóra Gyémánt more than expected).
Fields of papers citing papers by Nóra Gyémánt
This network shows the impact of papers produced by Nóra Gyémánt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nóra Gyémánt. The network helps show where Nóra Gyémánt may publish in the future.
Co-authorship network of co-authors of Nóra Gyémánt
This figure shows the co-authorship network connecting the top 25 collaborators of Nóra Gyémánt. A scholar is included among the top collaborators of Nóra Gyémánt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nóra Gyémánt. Nóra Gyémánt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 49 | |
| 2 | 38 | |
| 3 | 28 | |
| 4 | 18 | |
| 5 | The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line. | 25 |
| 6 | 53 | |
| 7 | Cinnamylidene ketones as potential modulators of multidrug resistance in mouse lymphoma and human colon cancer cell lines. | 10 |
| 8 | 15 | |
| 9 | Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids. | 35 |
| 10 | 3 | |
| 11 | 30 | |
| 12 | 79 | |
| 13 | In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. | 44 |
| 14 | Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones. | 16 |
| 15 | 18 | |
| 16 | 57 | |
| 17 | 26 | |
| 18 | 6 | |
| 19 | New silicon compounds as resistance modifiers against multidrug-resistant cancer cells. | 25 |
| 20 | Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids. | 63 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.